Holocene Advisors LP Increases Stake in The Chemours Company (NYSE:CC)

Holocene Advisors LP boosted its position in shares of The Chemours Company (NYSE:CCFree Report) by 1,058.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 194,465 shares of the specialty chemicals company’s stock after purchasing an additional 177,673 shares during the quarter. Holocene Advisors LP’s holdings in Chemours were worth $3,952,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. FMR LLC boosted its holdings in shares of Chemours by 3.5% during the 3rd quarter. FMR LLC now owns 18,142,202 shares of the specialty chemicals company’s stock valued at $368,650,000 after acquiring an additional 618,361 shares during the last quarter. Marshall Wace LLP boosted its holdings in shares of Chemours by 23.8% during the 2nd quarter. Marshall Wace LLP now owns 7,009,868 shares of the specialty chemicals company’s stock valued at $158,213,000 after acquiring an additional 1,347,710 shares during the last quarter. Khrom Capital Management LLC boosted its holdings in shares of Chemours by 54.6% during the 2nd quarter. Khrom Capital Management LLC now owns 3,456,626 shares of the specialty chemicals company’s stock valued at $78,016,000 after acquiring an additional 1,220,967 shares during the last quarter. Vaughan Nelson Investment Management L.P. boosted its holdings in shares of Chemours by 6.8% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 2,824,301 shares of the specialty chemicals company’s stock valued at $63,744,000 after acquiring an additional 178,625 shares during the last quarter. Finally, American Century Companies Inc. boosted its holdings in shares of Chemours by 26.7% during the 2nd quarter. American Century Companies Inc. now owns 1,811,957 shares of the specialty chemicals company’s stock valued at $40,896,000 after acquiring an additional 382,100 shares during the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Chemours news, SVP Alvenia Scarborough sold 7,500 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $20.64, for a total value of $154,800.00. Following the sale, the senior vice president now owns 16,645 shares in the company, valued at $343,552.80. The trade was a 31.06 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.47% of the stock is currently owned by corporate insiders.

Chemours Stock Performance

Shares of NYSE CC opened at $21.28 on Thursday. The stock has a market cap of $3.18 billion, a PE ratio of 42.56 and a beta of 1.80. The Chemours Company has a 1 year low of $15.10 and a 1 year high of $32.70. The firm has a fifty day moving average price of $19.81 and a 200-day moving average price of $21.14. The company has a debt-to-equity ratio of 6.05, a current ratio of 1.73 and a quick ratio of 0.92.

Chemours (NYSE:CCGet Free Report) last issued its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.08. Chemours had a return on equity of 29.48% and a net margin of 1.34%. The business had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same quarter in the prior year, the business posted $0.64 EPS. Chemours’s revenue for the quarter was up .9% compared to the same quarter last year. Equities analysts anticipate that The Chemours Company will post 1.35 earnings per share for the current fiscal year.

Chemours Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.00 dividend on an annualized basis and a yield of 4.70%. Chemours’s dividend payout ratio is presently 200.00%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CC shares. Barclays raised their price target on shares of Chemours from $21.00 to $23.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. Royal Bank of Canada lowered their price objective on shares of Chemours from $28.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 6th. BMO Capital Markets increased their price objective on shares of Chemours from $30.00 to $32.00 and gave the stock an “outperform” rating in a research note on Monday, October 7th. Morgan Stanley lowered their price objective on shares of Chemours from $30.00 to $25.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. Finally, The Goldman Sachs Group lowered their price objective on shares of Chemours from $29.00 to $23.00 and set a “neutral” rating on the stock in a research note on Tuesday, September 3rd. Five investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, Chemours currently has an average rating of “Hold” and a consensus target price of $24.88.

Read Our Latest Research Report on CC

Chemours Company Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

See Also

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.